 NEW ORLEANS--BUSINESS WIRE--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick Foti, LLC KSF are investigating the proposed sale of Strongbridge Biopharma plc NasdaqGS: SBBP to Xeris Pharmaceuticals, Inc. NasdaqGS: XERS. Under the terms of the proposed transaction, shareholders of Strongbridge will receive only 0.7840 shares of Xeris plus one contingent value right for each share of Strongbridge that they own. KSF is seeking to determi 